Mission EMpossible: Click to Save up to $4,800 on EM Treatments!
Finally! The cellulite treatment you have been waiting for. Aveli is a minimally invasive, FDA-cleared, one-time treatment for cellulite on the buttocks and thighs. During the procedure, Dr. Levine slides a handheld device beneath the skin to mechanically cut the septa, or connective-tissue bands, that pull down on the skin’s surface, contributing to dimples we know as cellulite.
While Avéli isn’t the first cellulite treatment to target dimple-forming septa, it is aiming to do so in a uniquely exacting way, allowing doctors to cut individual bands and receive tactile feedback verifying that the intended bands have, in fact, been broken. This greater accuracy should beget better results and fewer side effects—in a single session.
Like other cellulite solutions, Avéli acts only on discrete dimples—not textural issues related to skin laxity—so it’s important for doctors to do a thorough exam and determine who is a good candidate for the procedure.
Since Avéli is a heat-free treatment, it’s said to be safe for all skin type.
The treatment is performed under local anesthesia, so you shouldn’t feel any discomfort during the hour-long procedure. You will likely be sore, swollen, and bruised afterward.
Because of the injection of the local anesthetic and the manipulation of the tissues, Avéli can cause bruising, but it’s not as severe and does not last as long” as the bruising commonly seen with other cellulite treatments. (Again, she credits the instrument’s precision—and the fact that it doesn’t rupture surrounding blood vessels—for the less intense bruising post-procedure.)
In the (not-yet-published) Avéli clinical study, the most common side effects were mild pain within the first 24 hours along with bruising and tenderness that generally subsided within 30 days. Additionally, small areas of firmness can develop, but they’re “usually not visible or painful and typically resolve in a couple of months,” says the company.
Insertion points—where the tool pierces skin—may leak a clear or pink fluid for 24 to 48 hours post-treatment. Most trial patients returned to normal activities within this same time frame.
Results come into view once swelling and bruising fade, so figure about a month or so after treatment. The Avéli clinical study evaluated subjects at three months after their single session and saw sustained improvement. These subjects are now being followed out to 12 months, to assess the extent of the durability of their outcomes.